Renal cell carcinoma
Merck Sets Sights on Transforming Welireg into Blockbuster Drug, Expanding Treatment Scope for RCC Patients
Anika Sharma
In a strategic move to widen the impact of Welireg, Merck is poised to extend the drug’s influence and elevate ...
IVS-3001 been given Fast Track Designation by the FDA for RCC
SG Tylor
The FDA has granted fast track designation (FTD) to IVS-3001, an innovative chimeric antigen receptor (CAR) T-cell therapy, intended for ...
Advanced RCC Tumor Sequencing Identifies Host Signatures Associated with Immunotherapy Response
SG Tylor
In a single-center study presented at the 2023 Kidney Cancer Research Summit, researchers found that patients with metastatic renal cell ...
How to Counsel Patients on Immunotherapy Discontinuation in RCC
SG Tylor
Immunotherapy has revolutionized the treatment of metastatic renal cell carcinoma (RCC), a type of kidney cancer that is often resistant ...
